Ramipril/Telmisartan

雷米普利/替米沙坦

Report date: 2026/03/23 20:03:44

Base Information

Drug NameRamipril/Telmisartan
Drug Alias NameTelmisartan/RamiprilRamipril and TelmisartanTelmisartan and Ramipril
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin II Receptor Type 1Angiotensin-converting enzyme
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes RamiprilTelmisartan
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A